Literature DB >> 8386329

Transmembrane signaling through phospholipase C in human cortical membranes.

M A Wallace1, E Claro.   

Abstract

Stimulation of phosphoinositide-specific phospholipase C (PLC) by carbachol, dopamine and serotonin was measured by supplying exogenous [3H]phosphatidylinositol 4,5-bisphosphate to membranes prepared from human cortex dissected and frozen at autopsy. Subjects with Alzheimer's disease, Parkinson's disease or schizophrenia were compared to age-matched controls with no known neurological disorders. Stimulation of PLC by the neurotransmitters was dependent on the presence of GTP gamma S. Carbachol elicited the greatest stimulations of PLC followed by serotonin and then dopamine. The maximal stimulations of PLC evoked by a neurotransmitter were similar for the various categories of subjects except in Parkinson's patients, where dopamine failed to stimulate PLC beyond the activity attained with carbachol. In the presence of carbachol, the sensitivity of PLC to GTP gamma S was significantly increased in Alzheimer's membranes, but not in age-matched controls or Parkinson's. Overall, the experiments demonstrate the feasibility for using the exogenous substrate assay to study the functionality of the phosphoinositide transmembrane signaling system in human brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386329     DOI: 10.1007/bf01474676

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  21 in total

1.  Phosphoinositide-specific phospholipase C activation in brain cortical membranes.

Authors:  M A Wallace; E Claro; H R Carter; J N Fain
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 2.  Alzheimer's disease: is there a problem beyond recognition?

Authors:  C J Fowler; C O'Neill; A Garlind; R F Cowburn
Journal:  Trends Pharmacol Sci       Date:  1990-05       Impact factor: 14.819

Review 3.  Dopamine receptor subtypes: beyond the D1/D2 classification.

Authors:  P H Andersen; J A Gingrich; M D Bates; A Dearry; P Falardeau; S E Senogles; M G Caron
Journal:  Trends Pharmacol Sci       Date:  1990-06       Impact factor: 14.819

4.  Comparison of serotoninergic to muscarinic cholinergic stimulation of phosphoinositide-specific phospholipase C in rat brain cortical membranes.

Authors:  M A Wallace; E Claro
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

5.  Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes.

Authors:  L C Mahan; R M Burch; F J Monsma; D R Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  Carbachol in the presence of guanosine 5'-O-(3-thiotriphosphate) stimulates the breakdown of exogenous phosphatidylinositol 4,5-bisphosphate, phosphatidylinositol 4-phosphate, and phosphatidylinositol by rat brain membranes.

Authors:  E Claro; M A Wallace; H M Lee; J N Fain
Journal:  J Biol Chem       Date:  1989-11-05       Impact factor: 5.157

7.  Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq.

Authors:  A V Smrcka; J R Hepler; K O Brown; P C Sternweis
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

8.  Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease.

Authors:  R Cash; R Raisman; A Ploska; Y Agid
Journal:  J Neurochem       Date:  1987-10       Impact factor: 5.372

9.  D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation.

Authors:  J De Keyser; R Dierckx; P Vanderheyden; G Ebinger; G Vauquelin
Journal:  Brain Res       Date:  1988-03-08       Impact factor: 3.252

10.  Concerted CMP-dependent [3H]inositol labeling of phosphoinositides and agonist activation of phospholipase C in rat brain cortical membranes.

Authors:  E Claro; M A Wallace; J N Fain
Journal:  J Neurochem       Date:  1992-06       Impact factor: 5.372

View more
  9 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  A neurochemical approach for studying response to acetylcholine in Alzheimer's disease.

Authors:  J T Alder; I P Chessell; D M Bowen
Journal:  Neurochem Res       Date:  1995-07       Impact factor: 3.996

3.  Carnitine inhibits hydrolysis of inositol phospholipids induced by activation of metabotropic receptors.

Authors:  M Llansola; V Felipo
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

4.  [3H]PtdIns hydrolysis in postmortem human brain membranes is mediated by the G-proteins Gq/11 and phospholipase C-beta.

Authors:  R S Jope; L Song; R Powers
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

5.  Phospholipase Cbeta4 isozyme is expressed in human, rat, and murine heart left ventricles and in HL-1 cardiomyocytes.

Authors:  David Otaegui; Ramón Querejeta; Ander Arrieta; Ane Lazkano; Angel Bidaurrazaga; Jose Ramón Arriandiaga; Pablo Aldazabal; Mikel Asier Garro
Journal:  Mol Cell Biochem       Date:  2009-10-24       Impact factor: 3.396

6.  Effect of chronic haloperidol treatment on dopamine-induced inositol phosphate formation in rat brain slices.

Authors:  R Li; D M Chuang; R J Wyatt; D G Kirch
Journal:  Neurochem Res       Date:  1994-06       Impact factor: 3.996

7.  Deletion of PLCB1 gene in schizophrenia-affected patients.

Authors:  Vincenza Rita Lo Vasco; Giuseppina Cardinale; Patrizia Polonia
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

Review 8.  Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration.

Authors:  Thomas Ernest James Phillips; Emily Maguire
Journal:  Front Cell Neurosci       Date:  2021-03-26       Impact factor: 5.505

Review 9.  Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia.

Authors:  Seong-Wook Kim; Taesup Cho; Sukchan Lee
Journal:  Front Psychiatry       Date:  2015-11-17       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.